Robert C. Rose

4.6k total citations · 1 hit paper
58 papers, 3.8k citations indexed

About

Robert C. Rose is a scholar working on Epidemiology, Genetics and Immunology. According to data from OpenAlex, Robert C. Rose has authored 58 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 21 papers in Genetics and 18 papers in Immunology. Recurrent topics in Robert C. Rose's work include Cervical Cancer and HPV Research (32 papers), Virus-based gene therapy research (21 papers) and Immunotherapy and Immune Responses (10 papers). Robert C. Rose is often cited by papers focused on Cervical Cancer and HPV Research (32 papers), Virus-based gene therapy research (21 papers) and Immunotherapy and Immune Responses (10 papers). Robert C. Rose collaborates with scholars based in United States, South Africa and France. Robert C. Rose's co-authors include William Bonnez, Richard C. Reichman, Edith M. Lord, John G. Frelinger, Amit A. Lugade, Scott A. Gerber, Robert L. Garcea, Christopher Lane, Anna‐Lise Williamson and Xia Jin and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Virology.

In The Last Decade

Robert C. Rose

58 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor

2005 775 citations Amit A. Lugade, Scott A. Gerber et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert C. Rose United States	33	1.7k	1.3k	755	718	634	58	3.8k
Hideto Kaneshima United States	31	2.0k 1.1×	2.8k 2.1×	592 0.8×	1.1k 1.5×	1.0k 1.6×	58	6.0k
Niranjan Y. Sardesai United States	36	966 0.6×	1.6k 1.2×	463 0.6×	1.2k 1.7×	291 0.5×	120	3.9k
Kelledy Manson United States	31	1.1k 0.6×	2.1k 1.6×	664 0.9×	925 1.3×	397 0.6×	47	3.7k
Kathleen M. Brasky United States	34	2.0k 1.1×	865 0.7×	212 0.3×	798 1.1×	378 0.6×	73	4.1k
James A. Williams United States	32	927 0.5×	541 0.4×	311 0.4×	951 1.3×	436 0.7×	125	3.2k
Gary Rhodes United States	26	1.1k 0.6×	1.9k 1.4×	545 0.7×	1.4k 1.9×	643 1.0×	45	4.0k
Jean Boyer United States	46	2.0k 1.1×	4.7k 3.6×	863 1.1×	2.4k 3.4×	964 1.5×	140	7.5k
Michael A. Chattergoon United States	30	899 0.5×	2.3k 1.8×	318 0.4×	1.3k 1.9×	285 0.4×	58	3.8k
Dorotheé von Laer Germany	44	1.2k 0.7×	1.4k 1.1×	1.2k 1.5×	1.9k 2.7×	1.9k 3.0×	175	5.6k
Melissa Pope United States	41	1.1k 0.7×	4.4k 3.3×	470 0.6×	965 1.3×	308 0.5×	80	6.4k

Countries citing papers authored by Robert C. Rose

Since Specialization

Citations

This map shows the geographic impact of Robert C. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Rose more than expected).

Fields of papers citing papers by Robert C. Rose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Rose. The network helps show where Robert C. Rose may publish in the future.

Co-authorship network of co-authors of Robert C. Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Rose. A scholar is included among the top collaborators of Robert C. Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Rose. Robert C. Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rose, Robert C., Susanna L. Lamers, David J. Nolan, & Michael S. McGrath. (2015). Lymphatic and cancer tissues are a potential reservoir of replicating virus in virally suppressed ART + patients. Journal of Virus Eradication. 1. 7–7. 1 indexed citations

Rodrigo, W. W. Shanaka I., Christopher Lane, Soila Sukupolvi-Petty, et al.. (2009). Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype. Virology. 394(2). 175–182. 49 indexed citations

Kou, Zhihua, Huiyuan Chen, Matthew Quinn, et al.. (2007). Primary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In Vitro. Journal of Virology. 81(24). 13325–13334. 97 indexed citations

Kou, Zhihua, Matthew Quinn, Huiyuan Chen, et al.. (2007). Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. Journal of Medical Virology. 80(1). 134–146. 155 indexed citations

Malboeuf, Christine M., et al.. (2007). Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo. Vaccine. 25(17). 3270–3276. 35 indexed citations

Ryan, Elizabeth P., Christine M. Malboeuf, Matthew P. Bernard, Robert C. Rose, & Richard P. Phipps. (2006). Cyclooxygenase-2 Inhibition Attenuates Antibody Responses against Human Papillomavirus-Like Particles. The Journal of Immunology. 177(11). 7811–7819. 31 indexed citations

Rodrigo, W. W. Shanaka I., et al.. (2006). Differential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human FcγRIA (CD64) or FcγRIIA (CD32). Journal of Virology. 80(20). 10128–10138. 108 indexed citations

Lugade, Amit A., et al.. (2005). Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor. The Journal of Immunology. 174(12). 7516–7523. 775 indexed citations breakdown →

Sasagawa, Toshiyuki, Mayuko Tani, Walid Basha, et al.. (2005). A human papillomavirus type 16 vaccine by oral delivery of L1 protein. Virus Research. 110(1-2). 81–90. 30 indexed citations

10.

Sasagawa, Toshiyuki, et al.. (2003). Mucosal immunoglobulin‐A and ‐G responses to oncogenic human papilloma virus capsids. International Journal of Cancer. 104(3). 328–335. 19 indexed citations

11.

Passmore, Jo‐Ann S., Vanessa Burch, Enid Shephard, et al.. (2002). single‐cell cytokine analysis allows detection of cervical T‐cell responses against human papillomavirus type 16 L1 in women infected with genital HPV. Journal of Medical Virology. 67(2). 234–240. 16 indexed citations

12.

Marais, Dianne J., Jennifer M. Best, Robert C. Rose, et al.. (2001). Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia. Journal of Medical Virology. 65(1). 149–154. 4 indexed citations

13.

Evans, Thomas G., William Bonnez, Robert C. Rose, et al.. (2001). A Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult Volunteers. The Journal of Infectious Diseases. 183(10). 1485–1493. 150 indexed citations

14.

Rose, Robert C., et al.. (1999). Nuclear import of HPV11 L1 capsid protein is mediated by karyopherin α2β1 heterodimers. Journal of Cellular Biochemistry. 74(4). 628–637. 1 indexed citations

15.

Marais, Dianne J., Jo‐Ann S. Passmore, James Maclean, Robert C. Rose, & Anna‐Lise Williamson. (1999). A recombinant human papillomavirus (HPV) type 16 L1–vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV virus-like particles. Journal of General Virology. 80(9). 2471–2475. 32 indexed citations

16.

Rose, Robert C., et al.. (1998). Human Papillomavirus Type 11 Recombinant L1 Capsomeres Induce Virus-Neutralizing Antibodies. Journal of Virology. 72(7). 6151–6154. 107 indexed citations

17.

Shepherd, P, et al.. (1997). Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.. Journal of General Virology. 78(4). 917–923. 32 indexed citations

18.

Bryan, Janine T., et al.. (1991). Detection of human papillomavirus types 6 and 11 E4 gene products in condylomata acuminatum. Journal of Medical Virology. 34(1). 20–28. 14 indexed citations

19.

Bonnez, William, et al.. (1991). Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata. Journal of General Virology. 72(6). 1343–1347. 36 indexed citations

20.

Strike, David G., William Bonnez, Robert C. Rose, & Richard C. Reichman. (1989). Expression in Escherichia coli of Seven DNA Fragments Comprising the Complete L1 and L2 Open Reading Frames of Human Papillomavirus Type 6b and Localization of the 'Common Antigen' Region. Journal of General Virology. 70(3). 543–555. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact